COLUMBUS, Ohio, Oct. 17, 2016 /PRNewswire/ -- Medicare Advantage plans in over 100 cities will be recognized for exceptional value in the design of their medical and Part D prescription drug benefits available effective January 1. The 2017 Senior Choice Gold Award recipients were selected from Medicare Advantage plans across 47 states and Puerto Rico based on cost-sharing analysis conducted by HealthMetrix Research Inc. and MedicareNewsWatch.com. The 2017 Senior Choice Gold Award selections include special recognition for plans achieving at least 4-star overall ratings for quality and performance as reported by the Centers for Medicare & Medicaid Services (CMS).
According to HealthMetrix Research Inc. president Alan Mittermaier:
"This established industry award is unique for considering both forward-looking cost-sharing comparisons along with the recently announced quality and performance ratings. Each award recipient has demonstrated a commitment to excellence in the design of their 2017 Medicare plan benefits, copayments, deductibles and premiums including the Part D prescription drug benefits. Over 50% of the award recipients also achieved at least 4-star CMS overall ratings for exceptional performance that creates a higher bar for all Medicare Advantage competitors. HealthMetrix Research commends those organizations for this distinctive dual recognition."
The award criteria were based on 2017 benefits and cost-sharing approved by Medicare for the selected plans. Estimated annual out-of-pocket costs published on Medicare Plan Finder (www.Medicare.gov) include applicable plan copayments, deductibles and premiums adjusted for beneficiaries' health status (Excellent, Good, Poor). The HealthMetrix Research cost-sharing analysis is available at www.MedicareNewsWatch.com. HealthMetrix Research neither recommends nor endorses specific Medicare plans.
Last updated on: 18/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.